Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.
Trial locations(2 sites)
Canada
Eye Institute of Alberta, Royal Alexandra Hospital, Edmonton, Alberta Eye Institute of Alberta, Royal Alexandra Hospital, Edmonton, Alberta